Cash on Hand for Solventum (SOLV)
According to Solventum's latest reported financial statements, the company's latest reported cash and short-term investments is $878.00M USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
SOLV
Currently viewingCash on HandSwitch metric
Latest period
$878.00M
YoY change
+15.2%
5Y CAGR
N/A
Peak year (2025)
$878.00M
Latest annual
$878.00M
Cash on Hand history chart for Solventum (SOLV) from 2021 to 2025
Cash on Hand history table for Solventum (SOLV) from 2021 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $878.00M | +15.2% | ||
| 2024 | $762.00M | +292.8% | ||
| 2023 | $194.00M | +218.0% | ||
| 2022 | $61.00M | -33.0% | ||
| 2021 | $91.00M | — |
Cash on Hand values are taken from Solventum's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Solventum (SOLV) reported cash and short-term investments of $878.00M – grew 15.2% year-over-year.
2025 marks the peak cash and short-term investments at $878.00M, with the historical low of $61.00M recorded in 2022.
Solventum (SOLV) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $11.85B.
Solventum Cash on Hand by Year
Solventum Cash on Hand 2025: $878.00M
Solventum cash and short-term investments in 2025 was $878.00M, grew 15.2% from 2024. This figure represents the highest annual value in the available history.
Solventum Cash on Hand 2024: $762.00M
Solventum cash and short-term investments in 2024 was $762.00M, surged 292.8% from 2023.
Solventum Cash on Hand 2023: $194.00M
Solventum cash and short-term investments in 2023 was $194.00M, surged 218.0% from 2022.
Solventum Cash on Hand 2022: $61.00M
Solventum cash and short-term investments in 2022 was $61.00M, plunged 33.0% below 2021. This figure represents the lowest annual value in the available history.
Solventum Cash on Hand 2021: $91.00M
Solventum cash and short-term investments in 2021 was $91.00M.
See more financial history for Solventum (SOLV).
Sector peers — Cash on Hand
Companies in the same sector as Solventum, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Solventum's cash and short-term investments?
- Latest reported cash and short-term investments for Solventum (SOLV) is $878.00M (period ending December 31, 2025).
How has Solventum cash and short-term investments changed year-over-year?
- Solventum (SOLV) cash and short-term investments changed +15.2% year-over-year on the latest annual filing.
When did Solventum cash and short-term investments hit its highest annual value?
- Solventum cash and short-term investments reached its highest annual value of $878.00M in 2025.
What was Solventum cash and short-term investments in 2024?
- Solventum (SOLV) cash and short-term investments in 2024 was $762.00M.
What was Solventum cash and short-term investments in 2025?
- Solventum (SOLV) cash and short-term investments in 2025 was $878.00M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
SOLV Overview
Company profile, financial tools, and key metrics
SOLV Revenue Counter
Earns $263.98 every second. See per minute, hour, and day.
SOLV Earnings Counter
Earns $49.34 per second net profit. See per minute, hour, and day.
SOLV Economic Scale
Exceeds Montenegro's GDP. Compare with world economies.
SOLV What If Invested
What if you had invested $1,000? See historical returns from any date.
SOLV How It Makes Money
Discover visual breakdown of $8.32B in revenue — where it comes from and where it goes.
SOLV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
SOLV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
SOLV Daily Price Character
Steady · 48.6% historical win rate (green days). Streaks & record days.
SOLV Buybacks
See repurchase history & metrics. Shareholder yield & SBC comparison.